Catalogue number: |
PA2118 |
Price: |
$200.00 |
Reactivities: |
Human, Mouse, Rat |
Applications: |
Western Blot |
Size: |
100ug/vial |
Gene: |
TNFRSF11B |
Swiss prot: |
O00300 |
Form: |
Lyophilized |
Format: |
Each vial contains 5mg BSA, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3. |
Storage temp: |
At -20 degree C for one year. After reconstitution, at 4 degree C for one month. It can also be aliquotted and stored frozen at -20 degree C for a longer time.Avoid repeated freezing and thawing. |
Scientific background: |
Tumor necrosis factor receptor superfamily member 11B (TNFRSF11B), also known as OPG, is a protein that in humans is encoded by the TNFRSF11B gene. OPG is a cytokine receptor, and a member of the tumor necrosis factor (TNF) receptor superfamily. By analysis of radiation hybrids, TNFRSF11B gene was mapped to chromosome 8q24. OPG is a decoy receptor for the receptor activator of nuclear factor kappa B ligand (RANKL). By binding RANKL, OPG inhibits nuclear kappa B (NF-?B) which is a central and rapid acting transcription factor for immune-related genes, and a key regulator of inflammation, innate immunity, and cell survival and differentiation. OPG binding to RANKL on osteoblast/stromal cells, blocks the RANKL-RANK ligand interaction between osteoblast/stromal cells and ostepclast precursors. |
References: |
1. Krakauer T (2008). "Nuclear factor-kappa B: fine-tuning a central integrator of diverse biologic stimuli". Int. Rev. Immunol. 27 (5): 286 |
Additional info: |
A synthetic peptide corresponding to a sequence at the C-terminal of human TNFRSF11B, different from the related rat sequence by one amino acid, and different from the related mouse sequence by two amino acids. |